Evidence map›Paper›PMID 33564838›Full record

ArticleEuropean journal of preventive cardiology2022

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

Panteleimon E Papakonstantinou, Josip A Borovac, Aleksandra Gąsecka, Dario Bongiovanni, Hanne Ehrlinder, Michela Giustozzi, William A E Parker, Rui Azevedo Guerreiro

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of preventive cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Panteleimon E PapakonstantinouSecond Cardiology Department, Evangelismos Hospital, Ipsilantou 45-47, 106 76 Athens, Greece.
Josip A BorovacDepartment of Pathophysiology, University of Split School of Medicine, Croatia.
Aleksandra Gąsecka1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Dario BongiovanniTechnical University of Munich, School of Medicine, University hospital rechts der Isar, Department of Internal Medicine I, Munich, Germany.
Hanne EhrlinderDepartment of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Michela GiustozziInternal Vascular and Emergency Medicine and Stroke Unit, University of Perugia, Perugia, Italy.
William A E ParkerCardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID 0000-0002-7822-8852
Rui Azevedo GuerreiroCardiology Department, Hospital do Espirito Santo, Evora, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atrial FibrillationCOVID-19StrokeAnticoagulantsHumansWarfarinAnticoagulantsWarfarin

Identifiers

PMID33564838
PMCPMC7928961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.